Crinetics Pharmaceuticals, Inc. Common Stock and Additional Paid-In Capital
Crinetics Pharmaceuticals, Inc. (CRNX) had Common Stock and Additional Paid-In Capital of $2.86 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStocksIncludingAdditionalPaidInCapital · last filed 2026-08-03
- 2026-06-30: Common Stocks, Including Additional Paid in Capital $2.86B.
- 2026-03-31: Common Stocks, Including Additional Paid in Capital $2.83B.
- 2025-12-31: Common Stocks, Including Additional Paid in Capital $2.41B.
- 2025-09-30: Common Stocks, Including Additional Paid in Capital $2.36B.
| Period end | Common Stocks, Including Additional Paid in Capital |
|---|---|
| 2026-06-30 | $2.86B 10-Q · filed 2026-08-03 |
| 2026-03-31 | $2.83B 10-Q · filed 2026-05-07 |
| 2025-12-31 | $2.41B 10-Q · filed 2026-08-03 |
| 2025-09-30 | $2.36B 10-Q · filed 2025-11-06 |
| 2025-06-30 | $2.33B 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.30B 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.28B 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.70B 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.63B 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.60B 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.19B 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.14B 10-Q · filed 2023-11-07 |
| 2023-06-30 | $791.97M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $768.01M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $759.43M 10-K · filed 2024-02-28 |
| 2022-09-30 | $750.56M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $742.04M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $615.12M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $607.58M 10-K · filed 2023-02-28 |
| 2021-09-30 | $438.06M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $418.04M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $339.98M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $336.51M 10-K · filed 2022-03-30 |
| 2020-09-30 | $333.15M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $330.30M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $219.43M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $210.79M 10-K · filed 2021-03-30 |
| 2019-09-30 | $208.58M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $206.69M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $204.65M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $203.54M 10-K · filed 2020-03-09 |